True North Therapeutics

Bluefin Biomedicine

This biotechnology company develops first-in-class antibody medicines for patients with serious inflammatory and oncologic diseases.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Human Immunology Biosciences (HI-Bio)

This biotechnology company develops targeted immunotherapies for patients with rare, severe immune-mediated diseases, such as chronic kidney conditions and antibody-mediated transplant rejection.

Northern Biologics

This company develops antibody-based therapeutics targeting the tumour microenvironment to treat patients with cancer and fibrosis.

Triveni Bio

This biotechnology company develops antibody-based therapies for patients with immunological and inflammatory disorders using a genetics-informed precision medicine approach.

Clim Bio

This biotechnology company develops antibody-based medicines for patients with immune-mediated diseases such as lupus and IgA nephropathy.

Diagonal Therapeutics

This biotechnology company develops agonist antibody treatments for patients with rare genetic diseases like hereditary haemorrhagic telangiectasia and pulmonary arterial hypertension.